SAN FRANCISCO, Oct. 29 – Celera Genomics will include GeneFormatics’ structural proteomics database in its Discovery System, the companies announced Monday.

San Diego, Calif.-based GeneFormatics’ Proteomics Database contains approximately 7,000 novel biochemical function and structure assignments for potential drug targets in humans, according to the company.

Financial details of the agreement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.